Powala Christopher 4
4 · Aclaris Therapeutics, Inc. · Filed Dec 21, 2018
Insider Transaction Report
Form 4
Powala Christopher
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2018-12-18+1,625→ 139,889 total - Tax Payment
Common Stock
2018-12-18$6.30/sh−446$2,810→ 139,443 total - Exercise/Conversion
Restricted Stock Units
2018-12-18−1,625→ 1,625 total→ Common Stock (1,625 underlying)
Holdings
- 130,434(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units being reported in this Form 4.
- [F3]These shares are held by the Christopher V. Powala Aclaris Irrevocable Trust, for which Mr. Powala serves as trustee.
- [F4]On December 18, 2015, the reporting person was granted 6,500 restricted stock units, vesting in four equal annual installments beginning on December 18, 2016, subject to the reporting person's continuous service with the issuer as of the applicable vesting date.